Hírolvasó
News Brief: BFHI Network
Baby Friendly Hospital Initiative Breastfeeding Outcomes in Mothers with COVID-19 Infection During the First Weeks of the Pandemic in Spain
Background:Adherence to the Ten Steps of the Baby-Friendly Hospital Initiative has been shown to have a protective role for the initiation and maintenance of breastfeeding.Research Aims:(1) To determine the breastfeeding rate during the first 6 months of life in children of mothers diagnosed with COVID-19 infection at the time of birth; and (2) to assess the possible influence of being born in a center with Baby-Friendly Hospital Initiative accreditation.Methods:This was a two-group comparative longitudinal observational study of infants born to mothers with COVID-19 at the time of birth, between March 13–May 31, 2020 (the first wave of the pandemic) in Spain. Fourteen Spanish hospitals participated, five (35.7%) were Baby-Friendly Hospital Initiative accredited. Type of feeding was assessed prospectively at discharge, 1, 3, and 6 months of age. A total of 248 newborns were included in the study.Results:A total of 117 (47.3%) newborns were born in Baby-Friendly Hospital Initiative (BFHI) accredited centers. These centers applied skin-to-skin contact with greater probability (OR = 1.9; 95% CI [1.18, 3.29]) and separated the newborns from their mothers less frequently (OR = 0.46; 95% CI [0.26, 0.81]) than non-accredited centers. No differences were observed in relation to the presence of a companion at the time of birth. At discharge, 49.1% (n = 57) of newborns born in BFHI-accredited centers received exclusive breastfeeding versus 35.3% (n = 46) in non-accredited centers (p = .03). No differences were observed in breastfeeding rates throughout follow-up.Conclusions:The exclusive breastfeeding rate at discharge in children of mothers with COVID-19 infection at birth was higher in Baby-Friendly Hospital Initiative accredited centers, which most frequently applied skin-to-skin contact at birth as well as rooming-in.
The link between knowledge of the maternal diet and breastfeeding practices in mothers and health workers in Poland
JHL Offers Open Access Articles During World Breastfeeding Month
Celebrate and Share: Pass this Video On to Your Audience During World Breastfeeding Week
Book Review of Lactation: A Foundational Strategy for Health Promotion
Ma kezdődik a Szoptatás Világhete
A Szoptatás Világhetét 1992 óta ünnepeljük minden év augusztus 1–7. között a World Alliance for Breastfeeding Action (Fellépés a Szoptatásért Világszövetség, WABA) kezdeményezésére. A Szoptatás Világhetének kezdőnapja az Innocenti Nyilatkozat évfordulóját jelzi.
Az évről évre visszatérő kampány célja, hogy felhívja a figyelmet a szoptatás támogatásának fontosságára. A WABA évente meghatározza a világhét témáját, amely a szoptatásnak és a szoptatás támogatásnak különböző aspektusaira hívja fel a figyelmet. 2016 óta a téma mindig szoros kapcsolatban van az ENSZ által megfogalmazott fenntartható fejlődési célokkal is.
Az idei világhét témája: „A szoptatás védelme közös felelősségünk”A szoptatás minden gyermek számára létfontosságú a lehető legjobb életkezdéshez. Az anyatej a csecsemő első oltása, a legjobb táplálékforrás, támogatja az agy, az immunrendszer és valamennyi szervrendszer fejlődését. A szoptatás elősegíti az anya és a csecsemő közötti kötődést, továbbá jótékony hatással van mind az anya, mind a gyermek egészségére nemcsak rövid, hanem hosszú távon is.
Folytatás a SzoptatásInfó oldalon.
judit 2021. 08. 01., v – 22:29 Tags Szoptatás Világhete SzoptatásEight Easy Ways to Get Involved with World Breastfeeding Week
LEAARC News Brief: Lactation Education and Approval Review Committee News
Review of “Scanning for New Evidence on the Nutrient Content of Human Milk”
Correction to: Effect on breastfeeding practices of providing in-home lactation support to vulnerable women through the Canada Prenatal Nutrition Program: protocol for a pre/post intervention study
NEW! Breastfeeding Answers Pocket Guide 2021
Want a comprehensive lactation reference that fits into a pocket or tote?Looking for an up-to-date, compact resource for healthcare providers? Consider the new Breastfeeding Answers Pocket Guide, Second Edition (2021). For those shipping to U.S. addresses, it is now available HERE. At the top of that store page, you’ll also find links to its booksellers outside the U.S.
Written for those who help nursing families, this smaller, paperback version of my larger 2020 textbook Breastfeeding Answers, Second Edition (BA2e) includes all of its problem-solving strategies in a lightweight, easy-to-carry volume. Newly updated, it offers quick answers to the questions: “What do I need to remember in this situation?” and “What should I try next?”
What’s missing from this smaller volume? Thousands of citations, summaries of their contents, and explanations for its suggested strategies. What remains are the strategies themselves and the basic background details helpers need when assisting lactating families in a wide variety of common and unusual circumstances.
Intended for all levels of expertise, from beginners to advanced practitioners, this slim tome is ideal for hospitals, clinics, medical practices, public-health offices, and peer supporters. Think of the 2021 Pocket Guide as a portable companion to the larger, fully referenced BA2e. This indispensable resource provides easy access to research-based approaches to lactation challenges. It delivers what providers need to empower nursing families to meet their lactation goals.
Retail price is $43.95 USD, but the following volume discounts are available for bulk orders shipped to U.S. addresses.
VOLUME DISCOUNTS
Quantity Discount Price each
10 10% $39.56
20 15% $37.36
30 20% $35.16
40 25% $32.96
50 30% $30.77
We accept purchase orders. You can also receive volume discounts for orders placed through our online store HERE by requesting a discount code from our Customer Service at info@nancymohrbacher.com. Let us know which title(s) you’re ordering and how many of each you want, and we'll send you a code to enter at checkout.
Happy World Breastfeeding Month!
Noxious Alterations in Human Milk: An Ayurveda Perspective
Breastfeeding Motivation Predicts Infant Feeding Intention and Outcomes: Evaluation of a Novel Adaptation of the Treatment Self-Regulation Questionnaire
Background:Identifying those at risk for suboptimal breastfeeding outcomes remains critical for improving maternal and child health. Prenatal breastfeeding motivation may be a key predictor useful for identifying those who would benefit from additional breastfeeding support.Research Aims:To (1) validate a breastfeeding-specific adaptation of the Treatment Self-Regulation Questionnaire (TSRQ-BF); and (2) determine if breastfeeding motivation predicts prenatal breastfeeding intentions and early breastfeeding outcomes.Methods:Participants in their third trimester of pregnancy (N = 150) completed several instruments, including the TSRQ-BF and infant feeding intention, and could opt to participate in an assessment of early breastfeeding outcomes (by medical record review). TSRQ-BF subscales were derived from factor analysis, and multivariable regression was used to evaluate the association between TSRQ-BF subscale scores and breastfeeding intention and outcomes during the birth hospitalization.Results:Autonomous (related to personal values/beliefs regarding self) and Autonomous-Baby (values/benefits for the infant) subscale scores were positively associated with intended exclusivity (aOR [95% CI]: 2.22 [1.57, 3.30], 4.94 [2.49, 11.07], respectively) while higher scores on these subscales predicted longer time to planned cessation (aHR [95% CI]: 0.72 [0.61, 0.84],0.52 [0.34, 0.81]). Higher Amotivation (lack of motivation) scores were negatively associated with intended exclusivity (0.45 [0.26, 0.74]). Higher scores on Autonomous, Autonomous-Baby, and Controlled (avoidance of negative feelings/punishment or gaining reward) subscales were associated with greater odds of hospital exclusivity (aOR [95% CI]: 3.39 [1.75, 8.00], 3.44 [1.66, 9.04] and 6.05 [1.88, 29.04]) and lower odds of 2-day formula supplementation (aOR [95% CI]: 0.31 [0.14, 0.59],0.28 [0.11, 0.59], 0.19 [0.04, 0.62]).Conclusions:The TSRQ-BF predicted breastfeeding intent and outcomes, and may be helpful for identifying patients at risk for suboptimal breastfeeding outcomes before delivery.
Realigning Expectations With Reality: A Case Study on Maternal Mental Health During a Difficult Breastfeeding Journey
Introduction:Many mothers have the goal to breastfeed. However, more than 50% will have breastfeeding difficulty by the 3rd day of life. Mothers who are unable to meet their breastfeeding goals are at higher risk for anxiety, depression, embarrassment, and guilt. Those who stop breastfeeding need support and help resolving these feelings. This case study aims to describe one woman’s difficulty with mental health surrounding breastfeeding, her decision to bottle feed, and her successful transition back to direct breastfeeding.Main Issue:Barriers to the participant’s success with breastfeeding were pre-existing history of depression/anxiety, forceps delivery, uncontrolled perineal pain, infant physical trauma, and nipple/flow confusion. The decision to discontinue direct breastfeeding and start bottle feeding came after 2 months of anxiety, frustration, and persistence.Management:The participant followed her healthcare team’s recommendations of triple feeding, lactation support groups, pediatric chiropractic adjustments, and prescribed galactagogues. After 2 months of exhaustion and deliberation, she made the difficult decision to stop breastfeeding for nutritional benefits and switched to breastfeeding only for her infant’s pleasure and comfort. Lowered expectations allowed the dyad to heal and her son to transition to nearly exclusive breastfeeding at 4 months of life.Conclusion:Clinicians must be aware of the delicate balance between promoting breastfeeding for its nutritional value and health benefits and supporting a struggling mother with mental health needs.
Influence of Homogenization in the Physicochemical Quality of Human Milk and Fat Retention in Gastric Tubes
Background:The retention of human milk nutrients in gastric tubes used to feed premature infants is a challenge to be overcome.Research Aims:To evaluate (1) the performance of six homogenizers (mixing processor, piston valve, ultrasonic bath, ultraturrax, stirring mixer, and ultrasound probe) for the fat retention reduction in gastric tubes; (2) the influence of the best homogenization conditions on the fatty acid and protein profiles of human milk; and (3) the cost/benefit ratio for the inclusion of homogenization as a new step in human milk processing.Methods:The influence of different levels and times of homogenization on reducing fat retention of human milk in probes was evaluated in this comparative prospective cross-sectional study. After homogenization, human milk flowed through a gavage and infusion pump apparatus used for feeding. Fat content was quantified before and after feeding. The techniques that reduced fat globule sizes and/or promoted a lower percentage of fat holding were evaluated for efficiency, variations in the fatty acid and protein profiles, and energy density and operating costs.Results:Homogenization led to a reduction in fat retention in feeding probes. The mixer processor and the ultrasound probe reduced fat retention by 99.23% (SD = 0.07) and 99.95% (SD = 0.02), respectively, and did not negatively influence fatty acid and protein profiles. The mixer processor demonstrated low energy density and low cost for human milk processing.Conclusion:Homogenization promoted reduced fat retention in the feed probe and could help maintain fat nutrients of human milk during enteral feeding.
Human Milk Antibodies Against SARS-CoV-2: A Longitudinal Follow-Up Study
Background:Human milk contains antibodies against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) following Coronavirus Disease 2019 (COVID-19). These antibodies may serve as protection against COVID-19 in infants. However, the evolution of these human milk antibodies over time is unclear.Research Aim:To elucidate the evolution of immunoglobulin A (IgA) against SARS-CoV-2 in human milk after a SARS-CoV-2 infection.Methods:This longitudinal follow-up study included lactating mothers (N = 24) who had participated in the COVID MILK study. To assess the evolution of SARS-CoV-2 antibodies, serum and human milk samples were collected 14–143 days after the onset of clinical symptoms related to COVID-19. Enzyme-Linked ImmunoSorbent Assay was used to detect antibodies against the ectodomain of the SARS-CoV-2 spike protein.Results:SARS-CoV-2 antibodies remain present up to 5 months (143 days) in human milk after onset of COVID-19 symptoms. Overall, SARS-CoV-2 IgA in human milk seems to gradually decrease over time.Conclusion:Human milk from SARS-CoV-2 convalescent lactating mothers contains specific IgA antibodies against SARS-CoV-2 spike protein up to at least 5 months post-infection. Passive viral immunity can be transferred via human milk and may serve as protection for infants against COVID-19. Dutch Trial Register on May 1st, 2020, number: NL 8575, URL: https://www.trialregister.nl/trial/8575.
Promote World Breastfeeding Week: Add a Frame to Your Profile Image
SARS-CoV-2 Antibodies Detected in Mother’s Milk Post-Vaccination
BackgroundThe Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) pandemic has infected over 127 million people worldwide, with almost 2.8 million deaths at the time of writing. Since no lactating individuals were included in initial trials of vaccine safety and efficacy, research on SARS-CoV-2 vaccination in lactating women and the potential transmission of passive immunity to the infant through mother’s milk is needed to guide patients, clinicians, and policy makers on whether to recommend immunization during the worldwide effort to curb the spread of this virus.Research Aims(1) To determine whether SARS-CoV-2 specific immunoglobins are found in human milk after vaccination, and (2) to characterize the time course and types of immunoglobulins present.MethodsA longitudinal cohort study of lactating women (N = 7) who planned to receive both doses of the Pfizer-BioNTech or Moderna SARS-CoV-2 vaccine between December 2020 and January 2021 provided milk samples. These were collected pre-vaccination and at 11 additional timepoints, with the last sample at 14 days after the second dose of vaccine. Samples were analyzed for levels of SARS-CoV-2 specific immunoglobulins A and G (IgA and IgG).ResultsWe observed significantly elevated levels of SARS-CoV-2 specific IgG and IgA antibodies in human milk beginning approximately 7 days after the initial vaccine dose, with an IgG-dominant response.ConclusionsMaternal vaccination results in SARS-CoV-2 specific immunoglobulins in human milk that may be protective for infants.